Literature DB >> 2104731

CT of the extrahepatic bile ducts: wall thickness and contrast enhancement in normal and abnormal ducts.

S J Schulte1, R L Baron, S A Teefey, C A Rohrmann, P C Freeny, W P Shuman, M A Foster.   

Abstract

Recent reports have described thickening and enhancement of the extrahepatic bile duct wall on CT scans obtained after administration of IV contrast material. We undertook this study to establish parameters for the normal thickness and enhancement of the bile duct wall on CT, and to develop a differential diagnosis for thickening of the duct wall. Routine CT examinations of 100 patients without biliary disease were evaluated prospectively. The common hepatic duct and common bile duct could be visualized in 66% and 82% of cases, respectively; the walls of these ducts could be separately discerned in 59% and 52%. The mean thickness of the duct wall was 1 mm, with a maximal thickness of 1.5 mm. Wall enhancement was similar to (51%), slightly greater than (44%), or markedly greater than (5%) the enhancement of adjacent pancreatic parenchyma. A review of records covering a 5-year period identified 52 patients in whom CT showed thickening of the bile duct wall (greater than or equal to 2 mm). These patients could be categorized by seven underlying diseases, and analysis of the CT scans revealed four general patterns of thickening. Focal, concentric wall thickening in the distal common bile duct was associated with pancreatitis, pancreatic cancer, and common bile duct stones; focal, eccentric thickening tended to occur with cholangiocarcinoma and sclerosing cholangitis. Diffuse, concentric thickening was seen with acute cholangitis; diffuse, eccentric thickening was associated with oriental cholangiohepatitis and sclerosing cholangitis. Thickening of greater than 5 mm was seen only with cholangiocarcinoma. Enhancement of the duct wall in these groups varied and was of no predictive value. In summary, the extrahepatic bile ducts can be visualized in the majority of patients, and the normal duct wall should be 1.5 mm or less in thickness. Contrast enhancement of the duct wall occurs in patients without biliary tract disease and alone is predictive not predictive of pathology. Pancreatitis, pancreatic cancer, common bile duct stones, cholangiocarcinoma, sclerosing cholangitis, acute cholangitis, and oriental cholangiohepatitis are associated with thickening of the duct wall.

Entities:  

Mesh:

Year:  1990        PMID: 2104731     DOI: 10.2214/ajr.154.1.2104731

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  12 in total

Review 1.  Analytical review of diagnosis and treatment strategies for dominant bile duct strictures in patients with primary sclerosing cholangitis.

Authors:  Murad Aljiffry; Paul D Renfrew; Mark J Walsh; Marie Laryea; Michele Molinari
Journal:  HPB (Oxford)       Date:  2011-02       Impact factor: 3.647

2.  Role of radial endosonography in the diagnosis of acute cholangitis.

Authors:  Emrah Alper; Belkis Unsal; Zafer Buyrac; Behlul Baydar; Serdar Akca; Fatih Arslan; Yucel Ustundag
Journal:  Dig Dis Sci       Date:  2011-01-08       Impact factor: 3.199

3.  The role of diffusion-weighted MR imaging for differentiating benign from malignant bile duct strictures.

Authors:  Hyun Jeong Park; Seong Hyun Kim; Kyung Mi Jang; Seo-youn Choi; Soon Jin Lee; Dongil Choi
Journal:  Eur Radiol       Date:  2014-02-02       Impact factor: 5.315

4.  Determination of Diameter and Angulation of the Normal Common Bile Duct using Multidetector Computed Tomography.

Authors:  Jin-Seok Park; Don Haeng Lee; Seok Jeong; Soon Gu Cho
Journal:  Gut Liver       Date:  2009-12-31       Impact factor: 4.519

5.  The Impact of MDCT and Endoscopic Transpapillary Mapping Biopsy to Predict Longitudinal Spread of Extrahepatic Cholangiocarcinoma.

Authors:  Kyoji Ito; Yoshihiro Sakamoto; Hiroyuki Isayama; Yosuke Nakai; Takeyuki Watadani; Mariko Tanaka; Tetsuo Ushiku; Nobuhisa Akamatsu; Junichi Kaneko; Junichi Arita; Kiyoshi Hasegawa; Norihiro Kokudo
Journal:  J Gastrointest Surg       Date:  2018-05-15       Impact factor: 3.452

6.  Bile duct disease: prospective comparison of ERCP, CT, and fat suppression MRI.

Authors:  R C Semelka; J P Shoenut; M A Kroeker; H Hricak; G Y Minuk; C S Yaffe; A B Micflikier
Journal:  Gastrointest Radiol       Date:  1992

7.  Preoperative staging of biliary carcinoma using 18F-fluorodeoxyglucose PET: prospective comparison with PET+CT, MDCT and histopathology.

Authors:  Hiroyoshi Furukawa; Hiroki Ikuma; Koiku Asakura-Yokoe; Katsuhiko Uesaka
Journal:  Eur Radiol       Date:  2008-05-29       Impact factor: 5.315

8.  Evaluation of gallbladder and common bile duct size and appearance by computed tomography in dogs.

Authors:  Hyun-Young Park; Yu-Gyeong Cho; Young-Won Lee; Ho-Jung Choi
Journal:  J Vet Sci       Date:  2018-09-30       Impact factor: 1.672

9.  Comparison of Clinical and Radiologic Findings Between Perforated and Non-Perforated Choledochal Cysts in Children.

Authors:  Yu Jin Kim; Soo-Hyun Kim; So-Young Yoo; Ji Hye Kim; Soo-Min Jung; Sanghoon Lee; Jeong-Meen Seo; Sung-Hoon Moon; Tae Yeon Jeon
Journal:  Korean J Radiol       Date:  2022-01-04       Impact factor: 3.500

10.  Hounsfield unit density in the characterisation of bile duct lesions.

Authors:  Abdussamet Batur; Ulku Kerimoglu; Huseyin Ataseven
Journal:  Pol J Radiol       Date:  2019-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.